Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales

Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic.  

from Health and Science https://ift.tt/K9qO4au
https://ift.tt/xK4rnwz
https://ift.tt/xo1Xq6C